Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis
This study is currently recruiting participants.
Verified July 2011 by Kinki University
Study NCT01226147   Information provided by Kinki University

First Received on October 21, 2010.   Last Updated on July 21, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lupus Nephritis
Additional conditions recognized in this trial
Nephritis
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Glomerulonephritis
Immune System Diseases
Kidney Diseases
Lupus Erythematosus, Systemic
Urologic Diseases
Interventions listed in this trial
Tamibarotene
Additional drug interventions recognized in this trial
Benzoates
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Kinki University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services